Bumper Offer - Urjas oil Just @ Rs. 1
Nizral Tablet (10) is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Fungal Infections. Nizral Tablet (10) also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Nizral Tablet (10). Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Nizral Tablet (10) can also lead to other problems, which have been listed below. These side effects of Nizral Tablet (10) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Nizral Tablet (10)'s effect during pregnancy is Moderate and Safe while nursing. Further, the section on Nizral Tablet (10) related warnings talks about Nizral Tablet (10)'s effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Liver Disease must refrain from the use of Nizral Tablet (10) since this can cause severe adverse effects. The section on Nizral Tablet (10) contraindications lists all such conditions.
Besides this, Nizral Tablet (10) may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Nizral Tablet (10) is considered not safe while driving, and is not addictive.
Nizral Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Nizral Tablet (10) is used -
Moderate
Mild
Is the use of Nizral Tablet (10) safe for pregnant women?
Nizral may have some side effects during pregnancy. Pregnant women should discontinue the use of Nizral, and talk to their doctor, if they notice any discomfort.
Is the use of Nizral Tablet (10) safe during breastfeeding?
Nizral is safe for breastfeeding women.
What is the effect of Nizral Tablet (10) on the Kidneys?
There are no side effects of Nizral on the kidneys.
What is the effect of Nizral Tablet (10) on the Liver?
There may be severe side effects of Nizral on your liver. Do not take it unless a doctor says so.
What is the effect of Nizral Tablet (10) on the Heart?
Nizral is rarely harmful for the heart.
Nizral Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Nizral Tablet (10) unless your doctor advises you to do so -
Is this Nizral Tablet (10) habit forming or addictive?
Forming a habit of Nizral Tablet (10) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Nizral Tablet (10) as you may feel sleepy.
Is it safe?
Yes, Nizral Tablet (10) is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Nizral Tablet (10) in mental disorders is not effective.
Interaction between Food and Nizral Tablet (10)
You can take Nizral Tablet (10) with food.
Interaction between Alcohol and Nizral Tablet (10)
Taking Nizral Tablet (10) with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
